John Colwell to Blood Glucose
This is a "connection" page, showing publications John Colwell has written about Blood Glucose.
Connection Strength
0.695
-
Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 1998 Apr; 21(4):510-5.
Score: 0.116
-
Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):178-9.
Score: 0.099
-
Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992 Dec; 42(6):579-81.
Score: 0.080
-
Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J Clin Endocrinol Metab. 1984 Aug; 59(2):278-86.
Score: 0.045
-
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000 Oct; 23(10):1478-85.
Score: 0.034
-
Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 2000 Sep; 23(9):1316-20.
Score: 0.034
-
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999 Sep-Dec; 13(5-6):307-13.
Score: 0.032
-
Controlling type 2 diabetes: are the benefits worth the costs? JAMA. 1997 Nov 26; 278(20):1700.
Score: 0.028
-
Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes Care. 1996 Dec; 19(12):1375-81.
Score: 0.026
-
Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90.
Score: 0.026
-
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23.
Score: 0.024
-
Is it time to introduce metformin in the U.S.? Diabetes Care. 1993 Apr; 16(4):653-5.
Score: 0.021
-
Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71.
Score: 0.020
-
Effect of insulin infusion of pancreas on blood glucose. Diabetes. 1966 Feb; 15(2):123-6.
Score: 0.012
-
Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
Score: 0.012
-
QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS. Diabetes. 1963 Sep-Oct; 12:424-8.
Score: 0.011
-
EFFECT OF SITE OF ADMINISTRATION OF INSULIN ON BLOOD GLUCOSE AND FATTY ACID CONCENTRATIONS. Diabetes. 1963 Jul-Aug; 12:319-22.
Score: 0.010
-
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia. 1982 Jun; 22(6):430-6.
Score: 0.010
-
Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8.
Score: 0.009
-
Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Diabetes Care. 1998 Apr; 21(4):574-9.
Score: 0.007
-
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8.
Score: 0.007
-
Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan; 21(1):13-5.
Score: 0.005
-
Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep; 20(9):607-14.
Score: 0.005
-
Pheochromocytoma and insulin. Ann Intern Med. 1969 Sep; 71(3):668-9.
Score: 0.004
-
Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med. 1969 Aug; 71(2):251-6.
Score: 0.004
-
Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug; 16(8):560-5.
Score: 0.003
-
Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia. 1986 Oct; 29(10):685-9.
Score: 0.003
-
Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics. Diabetes. 1983 Oct; 32(10):908-14.
Score: 0.003
-
Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thromb Res. 1980 Jan 1-15; 17(1-2):261-6.
Score: 0.002
-
The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects. Clin Endocrinol (Oxf). 1977 Jun; 6(6):437-42.
Score: 0.002